Results 91 to 100 of about 33,171 (260)
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia [PDF]
3openA.
Ania +21 more
core +1 more source
Superior Vena Cava Syndrome in a Patient with Polycytemia Vera: Diagnosis and Treatment
Polycythemia vera is a myeloproliferative disorder characterized by thrombotic complications both in the arterial and venous systems. We report the case of a 55-year-old patient affected by polycythemia vera, presenting with acute superior vena cava ...
Salvatore Lentini +3 more
doaj +1 more source
Idiopathic noncirrhotic portal hypertension: current perspectives [PDF]
The term idiopathic noncirrhotic portal hypertension (INCPH) has been recently proposed to replace terms, such as hepatoportal sclerosis, idiopathic portal hypertension, incomplete septal cirrhosis, and nodular regenerative hyperplasia, used to describe ...
D'AMATI, Giulia +5 more
core +1 more source
Koljusisesed verevalumid tõelise polütsüteemiaga haigel kerge trauma järel [PDF]
Tõelise polütsüteemia diagnoosiga 54aastasel naishaigel kujunesid pärast kerget traumat – omalt jalalt kukkumist – ajusisene ja subduraalne verevalum vasemas ajupoolkeras.
Hein, Marju +3 more
core +2 more sources
Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low‐risk essential thrombocythemia and polycythemia vera [PDF]
Naseema Gangat +4 more
openalex +1 more source
Policitemia vera en un perro : su diagnóstico y su tratamiento [PDF]
En este artículo presentamos un caso clínico de policitemia vera (eritrocitosis) canina con un nivel de eritropoyetina en suero normal.
Anguiano, E. +3 more
core
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis [PDF]
Ruxolitinib, an orally bioavailable and selective inhibitor of Janus kinase 1 (JAK1) and JAK2, significantly reduces splenomegaly and disease-related symptoms in patients with myelofibrosis (MF).
Annunziata, M. +14 more
core +1 more source
The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia.
Ronan Le Calloch +13 more
doaj +1 more source
Polycythemia rubra vera and Hairy Cell Leukaemia / Reply [PDF]
G J Mufti +3 more
openalex +1 more source

